Actavis Recalls Trelstar Injectable Suspension Due to Labeling Error
Actavis is recalling 99 cartons of Trelstar 11.25 mg due to a labeling error where the vial was marked 3.75 mg. The product was distributed nationwide and in Puerto Rico.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a minor labeling error regarding the declared strength, which fits the criteria for moderate severity involving low-risk contamination or labeling issues without reported injuries.
Plain-English summary
Actavis Inc is voluntarily recalling 99 cartons of Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vial, 11.25 mg, Rx Only. The recall is due to a labeling error where the carton and kit were labeled as 11.25 mg, but the vial inside was labeled as 3.75 mg instead of 11.25 mg.
The affected product is identified by Lot # 13J081 with an expiration date of 05/15. The product was distributed nationwide and in Puerto Rico. The recall is classified as FDA Class II.
Healthcare providers and patients should discontinue use of the affected product and contact their pharmacist or healthcare provider for further instructions. The product is distributed by Watson Pharma, Inc., and manufactured by Debio RP, Switzerland.
The recalled product
- Product
- Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vial (NDC 52544-154-02) plus MIXJECT Single-Dose Delivery System containing 2 mL Sterile Water for Injection, USP per carton (NDC 52544-188-76), 11.25 mg, Rx Only, Dist. By: Watson Pharma, Inc., Morristown, NJ 0
- Manufacturer
- Actavis Inc
- Category
- Drug — Injectable Medication
- Hazard
- Affected units
- 99
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 13J081
- Exp 05/15
Distribution
Related recalls
Same manufacturer · Actavis Inc
See all →- ModerateActavis Recalls Levofloxacin Ophthalmic Solution Due to Impurity Failure
FDA (Drugs) · 2017-03-15
- ModerateActavis Recalls Glipizide Extended-Release Tablets Due to Dissolution Failure
FDA (Drugs) · 2017-02-22
- LowActavis Recalls Albuterol Sulfate Inhalation Solution Due to Impurities
FDA (Drugs) · 2017-02-01
- LowActavis Recalls Acetasol HC Otic Solution Due to Impurity Failure
FDA (Drugs) · 2016-08-31
- LowActavis Recalls Hydrocortisone and Acetic Acid Otic Solution Due to Impurities
FDA (Drugs) · 2016-08-31
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02